Free tool
FAERS Monitor: Lidocaine Hydrochloride Preservative Free
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 017584 or its brand name (Lidocaine Hydrochloride Preservative Free, Lidocaine Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
56,266
Serious
40,694
72% of reports
Hospitalization
20,189
Death reported
5,613
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective4,108
- nausea3,576
- pain3,541
- fatigue3,469
- headache3,296
- off label use3,070
- dyspnoea2,650
- diarrhoea2,417
- pneumonia2,228
- vomiting2,161
- dizziness2,037
- sinusitis1,990
- hypotension1,855
- fall1,842
- death1,825
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 316 |
| 2005 | 275 |
| 2006 | 327 |
| 2007 | 323 |
| 2008 | 402 |
| 2009 | 497 |
| 2010 | 581 |
| 2011 | 1,152 |
| 2012 | 1,299 |
| 2013 | 847 |
| 2014 | 1,187 |
| 2015 | 2,033 |
| 2016 | 3,318 |
| 2017 | 2,668 |
| 2018 | 3,430 |
| 2019 | 4,276 |
| 2020 | 5,560 |
| 2021 | 4,031 |
| 2022 | 4,061 |
| 2023 | 4,787 |
| 2024 | 5,375 |
| 2025 | 5,470 |
| 2026 | 4,047 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,997,893 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| sinusitisSignal | 1,990 | 7.4 | 7.1 | 10,814 |
| hypotensionSignal | 1,855 | 3.5 | 3.3 | 3,277 |
| pneumoniaSignal | 2,228 | 2.6 | 2.5 | 2,179 |
| painSignal | 3,541 | 2.2 | 2.1 | 2,262 |
| fallSignal | 1,842 | 2.1 | 2.0 | 1,035 |
| headache | 3,296 | 2.0 | 1.9 | 1,614 |
| dyspnoea | 2,650 | 1.8 | 1.7 | 877 |
| vomiting | 2,161 | 1.7 | 1.7 | 665 |
| nausea | 3,576 | 1.7 | 1.6 | 1,046 |
| fatigue | 3,469 | 1.7 | 1.6 | 960 |
| dizziness | 2,037 | 1.5 | 1.5 | 380 |
| diarrhoea | 2,417 | 1.4 | 1.3 | 285 |
| off label use | 3,070 | 1.3 | 1.3 | 236 |
| drug ineffective | 4,108 | 1.2 | 1.1 | 103 |
| death | 1,825 | 0.8 | 0.8 | 104 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.